A Phase II study of nab-Paclitaxel (nab-P) in patients with advanced non-small cell lung cancer with EGFR mutations after frontline tyrosine kinase inhibitor therapy

Cancer Treatment and Research Communications ◽

10.1016/j.ctarc.2021.100416 ◽

2021 ◽

pp. 100416

Author(s):

Christina Baik ◽

Sylvia Lee ◽

Kitty Cook ◽

Sarah Wallace ◽

Rebecca Wood ◽

...

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Tyrosine Kinase Inhibitor ◽

Kinase Inhibitor ◽

Phase Ii Study ◽

Egfr Mutations ◽

Small Cell Lung ◽

Tyrosine Kinase Inhibitor Therapy

Download Full-text

CLINICAL ANALYSIS OF AFATINIB IN EGFR-TYROSINE KINASE INHIBITOR NAÏVE PATIENTS WITH NON-SMALL CELL LUNG CANCER HABORING EGFR MUTATIONS

Respirology ◽

10.1111/resp.13207_77 ◽

2017 ◽

Vol 22 ◽

pp. 114-114 ◽

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Tyrosine Kinase Inhibitor ◽

Kinase Inhibitor ◽

Clinical Analysis ◽

Egfr Mutations ◽

Small Cell Lung ◽

Egfr Tyrosine Kinase Inhibitor

Download Full-text

Management of non-small cell lung cancer with EGFR mutation: the role of radiotherapy in the era of tyrosine kinase inhibitor therapy—opportunities and challenges

Journal of Thoracic Disease ◽

10.21037/jtd.2017.09.67 ◽

2017 ◽

Vol 9 (9) ◽

pp. 3385-3393 ◽

Author(s):

Bing Xia ◽

Shirong Zhang ◽

Shenglin Ma

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Tyrosine Kinase Inhibitor ◽

Egfr Mutation ◽

Kinase Inhibitor ◽

Small Cell Lung ◽

Tyrosine Kinase Inhibitor Therapy

Download Full-text

Re-biopsy for advanced non-small cell lung cancer after EGFR tyrosine kinase inhibitor therapy: CT characteristics of patients with T790M mutation and the use of various re-biopsy procedures

Annals of Oncology ◽

10.1093/annonc/mdx091.023 ◽

2017 ◽

Vol 28 ◽

pp. ii37-ii38

Author(s):

H.J. Koo ◽

M.Y. Kim ◽

C.-M. Choi ◽

J.C. Lee ◽

S. Park

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Tyrosine Kinase Inhibitor ◽

Kinase Inhibitor ◽

Small Cell Lung ◽

Egfr Tyrosine Kinase Inhibitor ◽

T790m Mutation ◽

Tyrosine Kinase Inhibitor Therapy

Download Full-text

Abstract B34: Overcoming resistance to EGFR-Tyrosine Kinase Inhibitor therapy in non-small cell lung cancer

Clinical Cancer Research ◽

10.1158/1078-0432.12aacriaslc-b34 ◽

2012 ◽

Vol 18 (3 Supplement) ◽

pp. B34-B34

Author(s):

Rafael Sierra ◽

Anderson Chang ◽

Jason Moffat ◽

Benjamin G. Neel ◽

Ming-Sound Tsao

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Tyrosine Kinase Inhibitor ◽

Cell Lung Cancer ◽

Kinase Inhibitor ◽

Small Cell Lung ◽

Egfr Tyrosine Kinase Inhibitor ◽

Tyrosine Kinase Inhibitor Therapy

Download Full-text

Abstract 1232: Overcoming resistance to EGFR-tyrosine kinase inhibitor therapy in non-small cell lung cancer

10.1158/1538-7445.am2012-1232 ◽

2012 ◽

Author(s):

J Rafael Sierra ◽

Anderson Chang ◽

Jason Moffat ◽

Benjamin G. Neel ◽

Ming-Sound Tsao

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Tyrosine Kinase Inhibitor ◽

Cell Lung Cancer ◽

Kinase Inhibitor ◽

Small Cell Lung ◽

Egfr Tyrosine Kinase Inhibitor ◽

Tyrosine Kinase Inhibitor Therapy

Download Full-text

New CT response criteria in non-small cell lung cancer: Proposal and application in EGFR tyrosine kinase inhibitor therapy

Lung Cancer ◽

10.1016/j.lungcan.2010.10.019 ◽

2011 ◽

Vol 73 (1) ◽

pp. 63-69 ◽

Author(s):

Ho Yun Lee ◽

Kyung Soo Lee ◽

Myung-Ju Ahn ◽

Hye Sun Hwang ◽

Ju Won Lee ◽

...

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Tyrosine Kinase Inhibitor ◽

Cell Lung Cancer ◽

Kinase Inhibitor ◽

Small Cell Lung ◽

Egfr Tyrosine Kinase Inhibitor ◽

Tyrosine Kinase Inhibitor Therapy

Download Full-text

New strategies to overcome limitations of reversible EGFR tyrosine kinase inhibitor therapy in non-small cell lung cancer

Lung Cancer ◽

10.1016/j.lungcan.2009.12.009 ◽

2010 ◽

Vol 69 (1) ◽

pp. 1-12 ◽

Author(s):

Robert C. Doebele ◽

Ana B. Oton ◽

Nir Peled ◽

D. Ross Camidge ◽

Paul A. Bunn

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Tyrosine Kinase Inhibitor ◽

Kinase Inhibitor ◽

Small Cell Lung ◽

Egfr Tyrosine Kinase Inhibitor ◽

Tyrosine Kinase Inhibitor Therapy ◽

Download Full-text

EGFR tyrosine kinase inhibitor (TKI) in patients with advanced non-small cell lung cancer (NSCLC) harboring uncommon EGFR mutations: A real-world study in China

Lung Cancer ◽

10.1016/j.lungcan.2016.01.018 ◽

2016 ◽

Vol 96 ◽

pp. 87-92 ◽

Author(s):

Jianlin Xu ◽

Bo Jin ◽

Tianqing Chu ◽

Xue Dong ◽

Haitang Yang ◽

...

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Tyrosine Kinase Inhibitor ◽

Kinase Inhibitor ◽

Egfr Mutations ◽

Small Cell Lung ◽

Egfr Tyrosine Kinase Inhibitor

Download Full-text

Tyrosine Kinase Inhibitor Therapy for Brain Metastases in Non-Small-Cell Lung Cancer: A Primer for Radiologists

American Journal of Neuroradiology ◽

10.3174/ajnr.a6477 ◽

2020 ◽

Vol 41 (5) ◽

pp. 738-750

Author(s):

C. Dodson ◽

T.J. Richards ◽

D.A. Smith ◽

N.H. Ramaiya

Keyword(s):

Lung Cancer ◽

Brain Metastases ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Tyrosine Kinase Inhibitor ◽

Cell Lung Cancer ◽

Kinase Inhibitor ◽

Small Cell Lung ◽

Tyrosine Kinase Inhibitor Therapy

Download Full-text

The relationship between tyrosine kinase inhibitor therapy and overall survival in patients with non-small cell lung cancer carrying EGFR mutations

Chinese Journal of Cancer ◽

10.5732/cjc.012.10160 ◽

2013 ◽

Vol 32 (3) ◽

pp. 136-140 ◽

Author(s):

Hidekazu Suzuki ◽

Tomonori Hirashima ◽

Norio Okamoto ◽

Tadahiro Yamadori ◽

Motohiro Tamiya ◽

...

Keyword(s):

Lung Cancer ◽

Overall Survival ◽

Small Cell Lung Cancer ◽

Tyrosine Kinase Inhibitor ◽

Kinase Inhibitor ◽

Egfr Mutations ◽

Small Cell Lung ◽

Tyrosine Kinase Inhibitor Therapy ◽

The Relationship

Download Full-text